Min Ruan Selected Research

Min Ruan Research Topics

Disease

16	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2024 - 10/2009
14	Neoplasms (Cancer) 12/2023 - 02/2010
10	Squamous Cell Carcinoma of Head and Neck 10/2023 - 02/2010
10	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 09/2021 - 03/2014
6	Neoplasm Metastasis (Metastasis) 10/2023 - 01/2018
6	Infections 01/2023 - 02/2014
4	Leukemia 01/2024 - 04/2012
4	Adenoid Cystic Carcinoma (Cylindroma) 01/2022 - 12/2018
4	Aplastic Anemia (Anemia, Hypoplastic) 01/2019 - 06/2012
4	Carcinogenesis 12/2018 - 04/2010
4	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2018 - 03/2015
4	Chromosome Aberrations (Chromosome Abnormalities) 04/2016 - 10/2009
3	Neutropenia 01/2023 - 04/2018
3	Philadelphia Chromosome 02/2021 - 06/2015
3	Mouth Neoplasms (Oral Cancer) 01/2018 - 01/2014
2	Residual Neoplasm 01/2024 - 09/2021
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 07/2022 - 02/2010
2	Thrombocytopenia (Thrombopenia) 01/2022 - 07/2015
2	Febrile Neutropenia 01/2022 - 11/2020
2	Hematologic Diseases (Blood Diseases) 09/2021 - 04/2016
2	Lymphatic Metastasis 06/2021 - 01/2016
2	Melanoma (Melanoma, Malignant) 10/2018 - 01/2018
2	Acute Promyelocytic Leukemia 01/2018 - 05/2012
2	Hemorrhage 04/2017 - 07/2015
2	Chromosome Breakage 08/2016 - 02/2013
2	Diamond-Blackfan Anemia (Anemia, Diamond Blackfan) 12/2012 - 06/2012
1	Drug-Related Side Effects and Adverse Reactions 12/2023
1	COVID-19 01/2023
1	Pneumonia (Pneumonitis) 01/2022
1	Multiple Myeloma 01/2021
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 06/2020
1	Hyperthermia 11/2018

Drug/Important Bio-Agent (IBA)

4	Biomarkers (Surrogate Marker)IBA 01/2022 - 07/2015
4	CytokinesIBA 01/2022 - 06/2014
4	Inosine Triphosphate (ITP)IBA 01/2018 - 03/2015
4	AutoantibodiesIBA 01/2018 - 03/2015
3	RNA (Ribonucleic Acid)IBA 10/2023 - 10/2018
3	Interleukin-6 (Interleukin 6)IBA 01/2022 - 06/2014
3	Tyrosine Kinase InhibitorsIBA 02/2021 - 06/2015
3	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2018
3	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2019 - 04/2012
3	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2019 - 02/2014
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2019 - 02/2014
3	Messenger RNA (mRNA)IBA 12/2018 - 01/2018
2	DNA (Deoxyribonucleic Acid)IBA 01/2024 - 02/2016
2	Circulating Tumor DNAIBA 01/2024 - 01/2021
2	Proteins (Proteins, Gene)FDA Link 10/2023 - 10/2018
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 01/2022
2	Interleukin-10 (Interleukin 10)IBA 01/2022 - 01/2018
2	Therapeutic UsesIBA 02/2021 - 10/2014
2	Circular RNAIBA 01/2021 - 01/2018
2	Long Noncoding RNAIBA 01/2021 - 10/2018
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 11/2020 - 02/2014
2	Core Binding Factors (Core-Binding Factor)IBA 07/2020 - 05/2020
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2018 - 03/2015
2	Mitomycin (Mitomycin-C)FDA LinkGeneric 08/2016 - 02/2013
1	Lysine (L-Lysine)FDA Link 12/2023
1	MethyltransferasesIBA 12/2023
1	Small Cytoplasmic RNAIBA 10/2023
1	VitaminsIBA 01/2023
1	nidogen (entactin)IBA 01/2022
1	Immunoglobulins (Immunoglobulin)IBA 01/2022
1	VimentinIBA 01/2022
1	MucinsIBA 01/2022
1	Decitabine FDA Link 01/2022
1	OrnidazoleIBA 01/2022
1	Azacitidine (5 Azacytidine)FDA Link 01/2022
1	Cadherins (E-Cadherin)IBA 01/2022
1	venetoclaxIBA 01/2022
1	DimetridazoleIBA 01/2022
1	Untranslated RNA (Noncoding RNA)IBA 01/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	Cladribine FDA LinkGeneric 01/2021
1	Hypoxanthine Phosphoribosyltransferase (Hypoxanthine Guanine Phosphoribosyltransferase)IBA 01/2021
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2021
1	Conditioned Culture MediaIBA 01/2021
1	apatinibIBA 01/2021
1	pegylated granulocyte colony-stimulating factorIBA 11/2020
1	CD19-specific chimeric antigen receptorIBA 01/2020
1	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2019
1	Etoposide (VP 16)FDA LinkGeneric 01/2019
1	WortmanninIBA 01/2019
1	Interferon-alpha (Interferon Alfa)IBA 01/2019
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2019
1	Microphthalmia-Associated Transcription FactorIBA 10/2018
1	Pemetrexed (MTA)FDA Link 04/2018
1	Competitive Endogenous RNAIBA 01/2018

Therapy/Procedure

16	Therapeutics 01/2023 - 12/2006
10	Drug Therapy (Chemotherapy) 01/2022 - 10/2009
2	Neck Dissection (Radical Neck Dissection) 07/2022 - 01/2016
2	Immunotherapy 01/2022 - 01/2018
2	Radiotherapy 01/2022 - 11/2018
2	Ligation 04/2016 - 01/2016
1	Drug Tapering 12/2023
1	Bariatric Surgery 01/2023
1	Hematopoietic Stem Cell Transplantation 02/2021
1	Salvage Therapy 01/2021
1	Induction Chemotherapy 01/2021
1	Length of Stay 11/2020
1	Transplantation 06/2020